Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PregInPoxVac: MVA-BN Mpox Vaccine in Infants and Children
NCT06844487Phase 3Active, not recruiting
- Start
- May 2025
- Primary completion
- Jun 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of JYNNEOS in mpox. Started May 2025; status: active, not recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on NCT06844487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06844487.